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Abstract.
Background: Previous research has identified a small subgroup of older adults that maintain a high level of cognitive
functioning well into advanced age. Investigation of those with superior cognitive performance (SCP) for their age is important,
as age-related decline has previously been thought to be inevitable.
Objective: Preservation of cortical thickness and volume was evaluated in 76 older adults with SCP and 100 typical older
adults (TOAs) assessed up to five times over six years.
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Methods: Regions of interest (ROIs) found to have been associated with super-aging status (a construct similar to SCP status)
in previous literature were investigated, followed by a discovery phase analyses of additional regions. SCPs were aged 70 + at
baseline, scoring at/above normative memory (CVLT-II) levels for demographically similar individuals aged 30–44 years
old, and in the unimpaired range for all other cognitive domains over the course of the study.
Results: In linear mixed models, following adjustment for multiple comparisons, there were no significant differences
between rates of thinning or volume atrophy between SCPs and TOAs in previously identified ROIs, or the discovery phase
analyses. With only amyloid- negative individuals in the analyses, again there were no significant differences between SCPs
and TOAs.
Conclusion: The increased methodological rigor in classifying groups, together with the influence of cognitive reserve, are
discussed as potential factors accounting for our findings as compared to the extant literature on those with superior cognitive
performance for their age.
Keywords: Cognitive aging, cortical thickness, cortical thinning, cerebral volume atrophy, older adult superior cognitive
performance, super-aging
INTRODUCTION
The majority of older adults experience some
decline in aspects of cognitive functions with increas-
ing age, including episodic memory, speed of pro-
cessing, and executive functions. However, previous
research [1–5] has identified a small subgroup of
older adults that maintain a high level of cog-
nitive functioning well into advanced age. The
constructs used to describe such superior cognitive
aging (e.g., “super-aging”) have utilized overlapping
but somewhat different criteria selected by different
researchers (e.g., minimum age criteria, or cognitive
domain assessed). However, all appear to have agreed
that this construct requires an individual to perform
cognitively at a level similar to those at least 20 to
30 years younger than their peer group. Investigation
of those with superior cognitive performance (SCP)
for their age is important, as age-related decline has
previously been thought to be inevitable. Differenti-
ating the changes intrinsic to aging, from those that
are common but may be preventable, for example
lifestyle factors, is becoming one of the most impor-
tant goals of aging research.
Table 1 presents the areas previously found to have
increased cortical thickness and volumes in older
adults with SCP compared to typical older adults
(TOAs; that is older adults that show the expected
age-related declines in cognitive function over time)
in the extant literature.
Cross-sectional studies
Fjell et al. [2] were the first group to discuss this
general SCP construct and described such individu-
als as ‘high fluid performers’ based on performance
on fluid reasoning and executive functioning tests.
Specifically, the authors split 74 participants (20–88
years of age) into high and low age groups, and
further divided each age group into high and aver-
age performers depending on results of these fluid
ability measures. They observed participants in the
high age group/high fluid ability group had large
areas of thicker cortex in comparison to the high age
group/average fluid ability group. The largest differ-
ences were found in the posterior parts of the right
cingulate gyrus. Additionally, differences were found
in some frontal and prefrontal areas between groups
in both hemispheres, as well as the medial structure
and the gyrus of the cingulate isthmus.
Sun et al. [3] used a definition of super-agers that
included individuals aged 60 and above (n = 17, mean
age of 67.8 years) and compared them with a group
of 23 TOAs (mean age of 66.2 years) and 41 young
adults (mean age of 24.5 years). They found that SAs
displayed significantly greater cortical thickness than
TOAs, but equivalent to young adults in the ante-
rior temporal cortex, rostral medial prefrontal cortex,
and anterior mid-cingulate cortex. These are key par-
alimbic and limbic nodes of the default mode and
salience networks usually engaged during attention,
motivation, and executive function tasks.
Harrison et al. [1] initially identified a specific sub-
set of older adults with SCP, described as “super
agers” (SAs). The authors proposed a definition
requiring an age of 80 or more, with episodic memory
performance within or above the average normative
values for 50–65-year-olds, and within one standard
deviation of the average range for their age on non-
memory measures particularly vulnerable to change
in aging and dementia. They found 12 individuals
meeting these SA criteria and compared them with
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Table 1
Areas found to have preserved cortical thickness and volume in published studies of individuals with superior cognitive performance














Thickness Posterior parts of cingulate
gyrus – right hemisphere
35 young (mean age 35.5,
SD 0.8)
Some frontal and prefrontal
areas in both hemispheres
Median split to divide into high
and low fluid performers
Medial structure and gyrus of
the cingulate isthmus
Superior memory and higher
cortical volumes in unusually
successful cognitive aging [1]
12 SA (mean age 83.5, SD 3.0) Episodic
memory
Volume Global volume
10 TOA (mean age 83.1, SD 3.4) Thickness Global cortex
14 middle aged (mean age 57.9,
SD 4.3)
Left anterior cingulate cortex
Morphometric and histologic
substrates of cingulate
integrity in elders with
exceptional memory capacity
[4]




Thickness Right rostral anterior cingulate
Posterior cingulate
Caudal anterior regions21 TOA (mean age 83.76,
SD 4.0)
18 middle aged (mean age
58.39, SD 3.7)
Youthful brains in older adults:
preserved neuroanatomy in the




17 SA (mean age 67.8, SD 6.0) Episodic
memory
Volume Right hippocampus
23 TOA (mean age 66.2, SD 5.1) Thickness Right angular gyrus
41 young adult (mean age 24.5,
SD 3.6)
Right superior frontal gyrus












Right inferior frontal gyrus
Left primary somatosensory
correct
Left lateral occipital cortex
Calcarine cortical regions 1
and 2
Rates of Cortical Atrophy in
Adults 80 Years and Older
With Superior vs Average
Episodic Memory [7]
24 SA (mean age 83.3, SD 3.5),
12 cognitively average elderly
adults (mean age 83.4, SD 3.8)
Episodic
memory
Volume Whole brain cortical volume
Brain Morphology, cognition,
and A in older adults with
superior memory performance
[6]








Prefrontal cortex103 TOA (mean age 75.9,
SD 4.5)
Rates of age- and amyloid
-associated cortical atrophy
in older adults with superior
memory performance [9]
172 SA, 172 Cognitively normal




Volume No significant associations
observed in white matter, gray
matter, hippocampus, and
white matter hyperintensity
SA, super-ager; SD, standard deviation; TOA, typical older adult.
10 demographically matched healthy elderly peers,
as well as 14 demographically matched middle-aged
controls aged 50–65. They found the SAs had a
region of left anterior cingulate cortex significantly
thicker than both comparison groups. They addi-
tionally observed significantly larger cortical volume
in the SAs compared to the same-aged peers, with
no difference between SAs and the middle-aged
group.
In a subsequent paper, Harrison and colleagues
studied a similar SCP group of older adults, which
included individuals aged 70 and above, described
as “successful agers”. They compared 26 success-
ful agers with 103 TOAs aged 70 and above. The
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authors observed greater cortical thickness in multi-
ple regions including the right anterior cingulate and
prefrontal cortex, and a greater hippocampal volume
in successful agers than TOAs [6].
Longitudinal studies
In addition to the cross-sectional analyses
described above, Harrison et al. [6] followed 19 of
the successful agers and 70 of the TOAs for at least
one additional MRI scan (mean 1.54 additional scans)
that allowed for observation of potential longitudi-
nal decline in these regions up to approximately 3–5
years later for this small sub-sample. Results showed
no difference in hippocampal volume atrophy rates,
or whole cortex cortical thinning between successful
agers and TOAs. While they observed that successful
agers displayed slower cortical thinning in a number
of left hemisphere areas including anterior cingulate,
middle cingulate, medial prefrontal, and insula, there
was no difference in rate of cortical thinning between
successful agers and TOAs when these areas were
combined bilaterally [6].
Cook et al. [7] found that 24 SAs (mean age
83.3 years) and 12 cognitively average elderly adults
(mean age 83.4 years) demonstrated statistically sig-
nificant mean annual percent whole-brain cortical
volume loss over 18 months; however, the volume
loss in the cognitively average elderly adults was
significantly greater compared with the SAs. Both
groups had similar levels of education and premor-
bid intellectual ability and had stable cognitive status
across the 2 visits to minimize inclusion of individu-
als with emerging dementia.
Dang et al. [8] recently assessed longitudinal
changes in global white matter, global grey matter,
hippocampal regions, and white matter hyperinten-
sity volumes over an 8-year follow-up in a cohort of
172 super-agers (using the aged 60 and above crite-
ria) and 172 Cognitively Normal For Age (CNFA)
individuals from the Australian Imaging Biomarkers
and Lifestyle (AIBL) study of ageing, investigating
the extent to which these rates are influenced by ele-
vated amyloid- (A). The authors concluded the
slowest rates of atrophy were observed in A- par-
ticipants, regardless of SA/CNFA status, and white
matter hyperintensity volume increased at the same
rate for all participants. Their results suggest that indi-
viduals classified as SA at baseline are not resilient
to the neurobiological changes associated with age or
A deposition.
The previous literature has several limitations, and
a multitude of questions remain unanswered. Lon-
gitudinal neuroimaging data is limited, for example
Dang et al. [8] examined global grey matter volume
but not cortical thickness or specific regional volume
or thickness other than hippocampus. Harrison et al.
[6] also examined only hippocampal volume with no
specific regional volume analyses, and thickness of
the whole cortex and only those cortical regions that
showed greater thickness in successful agers in their
cross-sectional analysis, and therefore trajectory of
change in regional cortical thickness and cerebral vol-
ume over extended periods with an adequate sample
size has not been thoroughly analyzed. It has been
shown that cortical thinning occurs with advancing
age [10], with global thinning apparent by middle
age; however, it is currently unknown whether older
adults with SCP experience similar rates of thinning
as their cognitively average peers, or whether they
resist these age-related changes. Secondly, from a
methodological standpoint, previous studies have not
established the stability of cognitive function used to
classify older adults with SCP (regardless of age cri-
teria) and TOAs. Specifically, previous studies relied
on a psychometric classification of SCP versus TOA
status, assessed on only a single occasion, leading
to the potential for misclassification in both groups.
A more reliable approach would be to confirm the
presence of superior cognitive performance over mul-
tiple assessments, thereby increasing the reliability of
SCP classification. Additionally, without longitudi-
nal assessment it is impossible to determine whether
those identified as TOAs may be in the early stages
of cognitive decline, and therefore whether the SCPs
are being compared to a TOA group that is truly aging
typically and not containing individuals with preclin-
ical dementia. Finally, the role of A positivity in the
trajectory of changes in cortical thickness and volume
has not been evaluated across specific brain regions
amongst older adults with SCP.
The current study evaluated longitudinal trajec-
tories of brain morphology in 76 SCPs and 100
TOAs by quantitatively comparing preservation of
cortical thickness and volume as measured by struc-
tural magnetic resonance imaging (MRI) scans. This
investigation included a well-characterized, Aus-
tralian older adult cohort drawn from the larger AIBL
study [10]. Specifically, the current study aimed to
evaluate whether the regions of interest (ROIs) iden-
tified in previous cross-sectional research as being
relevant for superior cognitive performance (Table 1)
show decreased cortical thinning and atrophy over
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time. In addition, we aimed to investigate other
potentially relevant regions not identified in previ-
ous cross-sectional studies, but which may show such
changes over time when analyzed longitudinally in a
discovery phase analysis. The current study utilized a
more stringent definition of SCP than previous stud-
ies. Specifically, participants in the SCP group had
to meet the cognitive criteria over at least three con-
secutive time-points, therefore, stability of SCPs and
TOAs cognitive ability and cognitively healthy sta-
tus could be assessed in the classification of SCP
and TOA. This allowed us to minimize inclusion
of individuals with emerging cognitive decline. We
hypothesized that SCPs would have reduced cortical
thinning and atrophy over time compared to TOAs
in the regions identified by the previous research
(Table 1). We did not have specific hypotheses for
the discovery phase analyses.
An important pathological process related to the
development of cognitive decline and Alzheimer’s
disease (AD) is A deposition. The analyses were
repeated following removal of participants above the
accepted cut-off values for significant A deposition
and therefore on a pathway to AD as opposed to
typical aging. This approach allowed the additional
investigation of the role of A status within the SCP
construct.
Of note, a commentary by Rogalski [11] was pub-
lished concurrently with the article by Dang et al.
[8] raising concerns that the relatively younger age
group used in the Dang et al. study (aged 60+) might
explain the non-significant findings and recommend-
ing examining only SAs aged 80 + . It is notable that
only one of the studies (Harrison et al, 2012 with
only 12 SAs) reviewed above used this age cut-off,
and the other relevant studies of super-aging or sim-
ilar constructs/terms used lower age thresholds (e.g.,
aged 60 or 70 rather than 80+). This is likely due
to the highly challenging nature of identifying such
unusual individuals. To balance the concerns regard-
ing an age at baseline that may be too low to allow
detection of relationships of interest to the SA or older
adult with SCP constructs, we used a criterion of
aged 70 years or greater at baseline. We subsequently
used a normative memory score for individuals aged
30–44 years rather than 50–65 years for classification
as SCP. This allowed a sample of SCPs of suffi-
cient size for longitudinal analysis which is lacking
in the current literature. In addition, we included a
cross-sectional post-hoc analysis in the subgroup of
the current cohort aged 80 + . This post-hoc analysis
utilized participants’ first MRI after they turned 80
years of age and investigated between group differ-
ences (SCPs versus TOAs) in ROIs identified in the
literature among this age group.
MATERIALS AND METHODS
Participants
This report describes data from 76 SCPs and 100
TOAs from the AIBL study [10]. Figure 1 shows the
sample selection process. Methods of recruitment,
assessment, inclusion and exclusion criteria for the
AIBL study have been detailed previously, and the
study has been approved by the institutional ethics
committees of Austin Health, St Vincent’s Health,
Hollywood Private Hospital and Edith Cowan Uni-
versity [10]. All participants were cognitively healthy
based on a comprehensive battery of neuropsycho-
logical measures, including the Clinical Dementia
Rating (CDR) scale and Mini-Mental State Exam-
ination (MMSE) score at four time points over 54
months (each 18 months apart). Participants com-
pleted brain MRI at one or more of five time points,
and positron emission tomography (PET) imaging to
quantify cerebral A load was also completed at the
corresponding time as the MRI. Of note, these par-
ticipants were drawn from the same AIBL cohort as
included in Dang et al. [8] study. However, our SCP
and TOA classification requirements differ substan-
tially from those used in that study. Therefore, the
SCP and TOA groups in the present study consist of
a subset of those used in the Dang et al. paper (i.e.,
76 of their 172 SAs). Specifically, we have excluded
all AIBL participants that did not meet our more
stringent longitudinal SCP and TOA requirements.
Cognitive assessments
A comprehensive neuropsychological battery of
well-validated measures was administered accord-
ing to standard protocols (described elsewhere [10,
12]). The battery assessed six cognitive domains (ver-
bal and visual memory, executive function, language,
attention and visuospatial functioning) at baseline,
and 18, 36, and 54 months follow up where available.
Defining older adult SCPs and TOAs
To define the SCP/TOA classification for analy-
ses, participants were aged at least 70 at baseline, and
were required to have completed the neuropsycholog-
ical battery on at least three of the four time points
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Fig. 1. Flow chart for sample selection HC, healthy control; MRI, magnetic resonance imaging; SCP, superior cognitive performer; TOA,
typical older adult.
(baseline, and 18, 36, and 54 months). SCPs must
have, 1) attained at least normative mean memory
(California Verbal Learning Test—Second Edition;
CVLT-II) long-delayed free recall scores for individ-
uals aged 30–44 (z scores ([value – mean]/standard
deviation) no less than –0.5), and 2) normative
scores in the unimpaired range (z above –1.5) for all
other domains based on same-aged peers at all time
points assessed. Use of long-delayed verbal mem-
ory scores has been common in previous research
in this area [1, 6–8] as it is one of the more sensi-
tive domains to age-related memory changes, as well
as neurodegenerative conditions [13]. TOAs must
not have scored in the impaired range (z –1.5 or
below) for same-aged peers on more than one cogni-
tive test at any of the time points assessed. That is, all
TOAs who displayed cognitive impairment based on
demographically adjusted norms were excluded. The
neuropsychological tests used to determine SCP and
TOA classification were, Logical Memory [14], Rey
Complex Figure Test delay [15], Stroop speed of col-
ors/speed of dots [16], Digit Span [17], Digit Symbol
Coding [17], Controlled Oral Word Association Task
[16], Category Fluency - animals + names [16], Fruit
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and Furniture - fluency switching [18], and Boston
Naming Test [19]. Normative data for all tests were
taken from the respective published manuals unless
otherwise indicated by Ellis et al. [10], and Supple-
mentary Table 1 details the mean standardized scores
for each group for these tests at baseline.
Magnetic resonance imaging
Participants underwent T1 weighted MRI using
the ADNI 3-dimensional (3D) Magnetization Pre-
pared Rapid Gradient Echo (MPRAGE) sequence
on 3T scanners at least once over five time points.
MPRage images were acquired on 3 scanners with
parameters as follow: Siemens Verio (TE = 2.98 ms,
TR = 2300 ms, FA = 9◦,resolution = 1 × 1 × 1.2 mm),
Siemens Tim Trio (TE = 2.98 ms, TR = 2300 ms, FA =
9◦, resolution = 1 × 1 × 1.2 mm), Siemens Avanto
(TE = 3.05 ms, TR = 2300 ms, FA = 9◦, resolution =
1 × 1 × 1.2 mm). All T1 weighted images were
processed using FreeSurfer software version 5.3.0
[http://surfer.nmr.mgh.harvard.edu/;20]. To improve
the reliability of longitudinal measures, the T1
weighted images of each subjects were analyzed
using the longitudinal stream of FreeSurfer [21].
There were no manual adjustments required for MRI
scans from this cohort, with no scans excluded based
on poor signal-to-noise ratio. Excessive motion was
evaluated visually, and no subjects were removed due
to motion artifacts. The Desikan-Killiany atlas was
used to compute the 40 cortical thickness and 47 vol-
ume measures. Cortical thickness is only able to be
reported where the thickness between grey matter and
white matter can be measured, for certain areas there
is no valid way to measure thickness, and therefore
only volume is reported. Individual participant scans
were taken approximately 18 months apart; however,
this varied between approximately 15 and 21 months
per participant. There was no difference in the time
intervals between SCP and TOA participants.
Positron emission tomography
PET neuroimaging was conducted using one
of the following A radiotracers: 11C-Pittsburgh
compound-B (PiB), 18F-Florbetapir (FBP), or 18F-
Flutemetamol (FLUTE). PET methods and pro-
cedures have been reported previously [22, 23].
Briefly, a 20-min acquisition was performed 40 min
post-injection of PiB, 50 min post-injection of FBP
and 90 min post-injection of FLUTE. Standardized
uptake value (SUV) data were summed and nor-
malized to a reference region (the cerebellar cortex
for PiB, the whole cerebellum for FBP, and the
pons for FLUTE) to generate a SUV ratio (SUVR).
CapAIBL was used for SUVR quantification [24].
The accepted cut-off values for significant A depo-
sition vary by radiotracer, for PiB the cut-off utilized
was ≥ 1.4, FLUTE ≥ 0.55, and FBP ≥ 1.05. All par-
ticipants with SUVR above or equal to the cut-offs
were classified as A+, and those below the threshold
were classified as A–. For the secondary analysis,
all participants who had one or more A+ scans were
removed from the dataset, with 49 SCPs and 53 TOAs
remaining.
Statistical analysis
Statistical analyses were performed using R ver-
sion 3.5.1 (R Foundation for Statistical Computing,
Vienna, Austria). A p-value < 0.05 determined a
significant result, and all p-values were adjusted
for multiple comparisons using false discovery rate
(FDR).
Means, standard deviations and percentages are
provided for all SCPs and TOAs, as well as for the
A- subgroups, with independent sample t-tests and
chi square (χ2) analyses as appropriate conducted
to evaluate group differences. A series of repeated
measures linear mixed effects model (LMM) anal-
yses (using maximum likelihood estimation and an
unstructured covariance matrix) were conducted to
examine the relationship between SCP and TOA sta-
tus, and time (actual time between MRI visits in
years) with respect to change in ROI cortical thick-
ness and volume. Age, sex, apolipoprotein (APOE)
ε4 allele status (the most common genetic risk factor
for AD), and MRI scanner (due to multiple scanners
being utilized for MRI scans) were entered as con-
founders, baseline age∗sex (to account for baseline
differences per participant), SCP/TOA status∗time
interactions to investigate changes in ROI over time
dependent upon SCP/TOA status, and a random
intercept to account for multiple observations per
participant. A random slope was not fitted due to lim-
ited sample size. This was repeated for the A- only
groups. All participants irrespective of their number
of scans were used in the LMM to reduce parameter
variation, however only those with three or more time
points were used in the calculation of the time related
changes between SCP/TOA groups.
RESULTS
Although the TOA group was not selected to
be matched to the SCP group, there were no
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Table 2
Descriptive statistics for superior cognitive performers and typical older adults
SCP TOA p-values for A- A- p-values
(n = 76) (n = 100) SCP and SCP TOA for A-
TOA (n = 49) (n = 53) SCP and
differences TOA
differences
Age at baseline, y 75.58 ± 3.9 76.70 ± 4.4 0.830 75.33 ± 3.6 75.74 ± 4.1 0.600
Sex, male; n (%) 32 (42) 44 (44) 0.878 20 (41) 21 (40) 0.689
Education ≤ 12 y; n (%) 27 (36) 48 (48) 0.124 19 (39) 22 (42) 0.840
Presence of APOE 4 allele; n (%) 15 (20) 23 (23) 0.712 5 (10) 7 (13) 0.547
Country of birth, Australia∗; n (%) 55 (72) 80 (80) 0.235 36 (73) 39 (74) 0.860
A +ve; n (%) 27 (36) 47 (47) 0.124
If not otherwise described, data are presented as mean ± standard deviation of the mean. A, amyloid-; APOE, Apolipoprotein ε4; SCP,
superior cognitive performer; TOA, typical older adult; y, years. Characteristics compared using independent samples t-test for continuous
variables and χ2 for categorical variables. ∗Other countries of birth include United Kingdom, Singapore, Netherlands, Egypt, South Africa,
Zimbabwe, Malaysia, Sweden, Germany.
Table 3
The number of participants with MRIs at each time point for the cohort as a whole and for the subset of
only A negative participants
Time point 1 Time point 2 Time point 3 Time point 4 Time point 5
SCP 24 30 21 41∗ 37
TOA 31 31 21 43 32
A –ve SCP 17 22 13 27 22
A –ve TOA 16 17 10 24 18
A, amyloid-; AIBL, Australian Imaging, Biomarkers, and Lifestyle study; MRI, magnetic resonance imaging;
SCP, superior cognitive performer; TOA, typical older adult. ∗Note: Only a small number of AIBL participants
were imaged at baseline due to funding restraints. As more funding became available over the years, a greater
number were imaged. Furthermore, the number of participants at time point 3 was lower than time point 4 as it
was at time point 4 where AIBL initiated recruitment of enrichment subjects (participants who were recruited from
baseline in 2006 were termed “inception”).
statistically significant differences in the demo-
graphics between groups (Table 2). The 76 SCPs
comprised 42% males, whilst the 100 TOAs com-
prised 44% males. Average age did not differ between
the two groups (SCPs: 75.58 ± 3.9 versus TOAs:
76.70 ± 4.4). Thirty-six percent of SCPs and 48% of
TOAs had less than 13 years of education, and 20%
of SCPs and 23% of TOAs had one or more APOE ε4
alleles.
We also analyzed the A- only subgroup. With
regard to demographics of these subgroups (that is,
A- SCPs and TOAs), again there were no statis-
tically significant differences. Of the 49 SCPs in
this subsample, 41% were males; of the 53 TOAs,
40% were males. Average age did not differ between
the two groups (SCP: 75.33 ± 3.6 versus TOA:
75.74 ± 4.1). Thirty-nine percent of SCPs and 42%
of TOAs had less than 13 years of education, and 10%
of SCPs and 13% of TOAs had one or more APOE
ε4 alleles (Table 2). The total number of SCPs and
TOAs with MRI data available at each time point is
reported in Table 3. Of the total number of partici-
pants, 88 (51 SCP, 37 TOA) had at least two MRI
scans, and 31 participants (18 SCP, 13 TOA) had at
least three MRI scans.
We conducted multiple LMM analyses to assess
the association between preservation of brain mor-
phology in SCPs and TOAs in ROIs identified in the
previous literature (Table 1). There were no signifi-
cant differences between both overall cortical thick-
ness and volumetric measures, nor between rates of
cortical thickness decline or volume atrophy between
SCPs and TOAs in these ROIs preceding or follow-
ing FDR adjustment (Table 4). In the A- subgroup
analysis, preceding FDR adjustment, there was a
significant association in the medial orbitofrontal cor-
tical thickness in the right hemisphere (=–0.0023;
p = 0.032; Fig. 2). However, following FDR adjust-
ment, results were non-significant (Table 4).
Following the initial analyses, additional regions
not previously identified as important in the SCP lit-
erature were examined (45 volume and 22 cortical
thickness regions). Assessing both the main effects
for differences in cortical thickness and volumetric
measures, and the atrophy in either cortical thick-













Results of linear mixed models examining the association between change in cortical thickness and cerebral volume in regions of interest previously identified in published literature and superior
cognitive performer status
Left Hemisphere Right Hemisphere A Negative Left Hemisphere A Negative Right Hemisphere
Brain area Volume or Beta p FDR Beta p FDR Beta p FDR Beta p FDR
Thickness (SE) Adjusted p (SE) Adjusted p (SE) Adjusted p (SE) Adjusted p
Cerebral Cortex Thickness –0.0001 (0.003) 0.979 0.979 –0.0022 (0.003) 0.490 0.920 –0.0022 (0.004) 0.553 0.749 –0.0033 (0.004) 0.389 0.749
Caudal Anterior
Cingulate
Thickness –0.0088 (0.006) 0.175 0.920 –0.0046 (0.006) 0.418 0.920 –0.011 (0.008) 0.149 0.749 –0.0061 (0.007) 0.403 0.749
Inferior Parietal Thickness –0.0046 (0.004) 0.294 0.920 –0.0053 (0.005) 0.283 0.749
Isthmus Cingulate Thickness –0.0034 (0.006) 0.571 0.920 –0.0090 (0.005) 0.077 0.841 –0.0030 (0.008) 0.697 0.749 –0.0066 (0.006) 0.253 0.749
Lateral Occipital Thickness –0.0033 (0.004) 0.348 0.920 –0.0063 (0.004) 0.139 0.749
Lateral Orbitofrontal Thickness –0.0058 (0.005) 0.223 0.920 –0.0048 (0.005) 0.366 0.920 –0.0096 (0.006) 0.118 0.749 –0.0028 (0.007) 0.676 0.749
Medial Orbitofrontal Thickness 0.0023 (0.005) 0.664 0.978 –0.0093 (0.005) 0.087 0.841 –0.0027 (0.007) 0.687 0.749 –0.0153 (0.007) 0.031 0.749
Middle Temporal Thickness –0.0001 (0.004) 0.972 0.979 –0.0021 (0.005) 0.681 0.749
Pars Opercularis Thickness –0.0007 (0.005) 0.877 0.978 –0.0089 (0.005) 0.072 0.841 –0.0064 (0.006) 0.276 0.749 –0.0095 (0.006) 0.108 0.749
Pars Orbitalis Thickness –0.0078 (0.006) 0.198 0.920 –0.0039 (0.006) 0.517 0.920 –0.0102 (0.008) 0.178 0.749 –0.0097 (0.007) 0.187 0.749
Pars Triangularis Thickness –0.0002 (0.005) 0.972 0.979 –0.0033 (0.005) 0.549 0.920 –0.0030 (0.007) 0.652 0.749 –0.0049 (0.007) 0.490 0.749
Peri Calcarine Thickness –0.0015 (0.005) 0.772 0.978 –0.0010 (0.005) 0.853 0.978 –0.0018 (0.006) 0.760 0.787 0.0005 (0.006) 0.934 0.934
Post Central Thickness 0.0006 (0.004) 0.870 0.978 –0.0034 (0.004) 0.454 0.749
Posterior Cingulate Thickness –0.0013 (0.005) 0.799 0.978 –0.0052 (0.004) 0.165 0.920 0.0030 (0.006) 0.617 0.749 –0.0021 (0.005) 0.664 0.749
Rostral Anterior
Cingulate
Thickness –0.0040 (0.006) 0.509 0.920 –0.0045 (0.007) 0.526 0.749
Rostral Middle
Frontal
Thickness –0.0012 (0.004) 0.769 0.978 0.0009 (0.004) 0.833 0.978 –0.0053 (0.005) 0.288 0.749 –0.0026 (0.006) 0.640 0.749
Superior Frontal Thickness –0.0025 (0.004) 0.571 0.920 –0.0027 (0.004) 0.518 0.920 –0.0035 (0.005) 0.472 0.749 –0.0029 (0.005) 0.570 0.749
Insula Thickness –0.0041 (0.004) 0.333 0.920 0.0004 (0.005) 0.946 0.978 –0.0030 (0.005) 0.565 0.723 –0.0028 (0.007) 0.683 0.723
Cerebral Cortex Volume 0.0075 (0.024) 0.752 0.978 –0.0087 (0.024) 0.721 0.978 –0.0054 (0.030) 0.857 0.787 –0.0181 (0.031) 0.559 0.723
Hippocampus Volume –0.0005 (< 0.001) 0.301 0.920 –0.0003 (< 0.001) 0.489 0.920 –0.0004 (0.001) 0.428 0.749 –0.0006 (0.001) 0.367 0.723
Beta coefficients represent the comparison of brain region cortical thickness and volume over time between typical older adult and superior cognitive performers with associated standard error
A, amyloid-; FDR, false discovery rate; SE, standard error. Bold indicates statistical significance at p < 0.05 before FDR Adjustment. A negative  coefficient indicates volume/cortical atrophy
over time, with strong negative coefficients indicating greater atrophy relative to the error and sample size.
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Fig. 2. Example representation of differences in cortical thickness
trajectory between SCPs and TOAs: right medial orbitofrontal pre-
frontal cortex FDR, false discovery rate; RH, right hemisphere;
SCP, superior cognitive performer, super-ager; TOA, typical older
adult. Black Line: SCPs; Red Line: TOAs.
one region, right hemisphere rostral anterior cingu-
late, with significantly greater volume ( = –0.0142,
p > 0.001) in SCPs as compared with TOAs. While
there was an overall difference in volume between
groups, the rate of change in volume in this region was
not significantly different over time (p > 0.050). Sup-
plementary Table 4 provides the main effects results
from both the ROI and additional analyses in the
cohort as a whole. At the nominal significance level,
there were two associations observed between rate of
volume atrophy between SCPs and TOAs in the right
banks of the superior temporal sulcus ( = –0.0007;
p = 0.025) and left hemisphere lateral orbitofrontal
cortex volume ( = 0.0033; p = 0.021). However, fol-
lowing FDR adjustment, no significant differences in
these regions remained (Supplementary Tables 2–4).
In the A- subgroup analysis, higher volume loss
was observed in the TOAs compared with the SCPs
in the right banks of the superior temporal sulcus
( = –0.0011; p = 0.006) and the right hemisphere
medial orbitofrontal region ( = –0.0023; p = 0.032).
However following FDR adjustment, these differ-
ences were no longer significant (Supplementary
Tables 2 and 3).
Given the sample size of the two separate groups
with three or more MRI measures, and the longitu-
dinal nature of the study, we computed an estimated
required sample size for the LMM to be able to detect
a significant difference in cortical thickness atrophy
over time [25]. We used one region for volume (left
hemisphere cortical volume) and one region for cor-
tical thickness (right hemisphere cortical thickness)
and using the power calculations adapted from Liu
& Liang et al. (1997) computed the sample size
(using alpha at 0.05, and 80% power) that would be
needed to be able to find a difference between the two
slopes representing cortical thickness atrophy. Rate
of cortical volume loss per year for a healthy normal
population over the age of 60 has been estimated to be
approximately 0.5% per year [26, 27]. If a SCP partic-
ipant lost up to ∼50% less volume than a typical ager
(0.25%/year), then using this approximated attenua-
tion of volume loss, and the model estimates given
by the LMM (up to three time points, adjusting for
age, gender, APOE 4 allele status and scanner), the
required sample size to detect a difference between
the two slopes (SCP versus TOA) would be > 8,000
participants per group. Changing the magnitude of the
difference in atrophy either up or down around 50%
either decreases or increases the expected sample
size respectively. Such large expected sample sizes
demonstrate that the proportion of variance in the
MRI measure to the small changes in volume which
may occur between the SCP/TOA group is too large
to see any significant changes over time.
As described above, Rogalski’s [5] definition of
SA utilizes those aged 80 + at baseline, and poten-
tially the SA phenomenon may only be expressed
after this age. In the current study, the sample of
participants 80 + was too small to attain meaningful
statistical results using longitudinal analysis, but a
cross-sectional between-groups analysis of a subsam-
ple of this cohort was completed using the first MRI
scan obtained after reaching 80. There were 20 par-
ticipants in the SCP group, and 26 participants in the
TOA group of the present cohort who turned 80 years
old during the study time frame and were therefore
included in this additional analysis. Of interest was
the relatively high proportion of the SCP group who
were A+(40%) as compared with the TOA group
(69%), although this did not reach statistical signif-
icance (χ2 = 2.83, p = 0.092). MRI scan results for
previously identified neural regions did not differ sig-
nificantly for volume or thickness between groups in
models adjusting for age, gender, and APOE 4 allele
status (data not shown).
DISCUSSION
This study provides several novel contributions to
the literature examining older adults with superior
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cognitive performance. Specifically, to the authors’
knowledge, this is the first published study to evaluate
brain morphology in SCPs compared to TOAs, 1) lon-
gitudinally, with a relatively large sample size over an
extended period (76 SCPs and 100 TOAs followed for
up to 72 months) with detailed specific neural regions,
2) ensuring reliable classification of SCP and TOA by
requiring stability of cognitive performance over the
course of the study and excluding individuals display-
ing non-age-related cognitive decline/emergent AD,
and 3) extending the literature on SCPs by evaluating
the role of A load.
In summary, we evaluated longitudinal trajecto-
ries of cortical thickness and volume by comparing
preservation of ROIs identified as potentially rele-
vant to SCP status in the extant literature, as well
as discovery-phase analyses of additional neural
regions. After adjusting for FDR, there were no sig-
nificant differences in the rate of cortical thickness
decline or volume atrophy between SCPs and TOAs
in any neural regions.
Our results were partially consistent with Harri-
son et al. [6] who found that the longitudinal rate of
hippocampal volume atrophy and whole cortex cor-
tical thinning was not significantly different between
successful agers and TOAs. Of note, however, Har-
rison et al. [6] also concluded that their successful
agers displayed attenuated left hemisphere cortical
thinning in the anterior cingulate cortex, middle cin-
gulate, medial prefrontal, and insula over an average
follow up period of 4.5 ± 2.7 years for successful
agers and 3.5 ± 1.9 years for TOAs. Additionally, our
findings were not consistent with the small number of
cross-sectional studies of older adults with SCP (e.g.,
[1–3], which appeared to show that there were signif-
icant differences in cortical thickness and/or volume
between those with SCP and TOAs in multiple neural
regions. Of note, this was true both in the primary lon-
gitudinal analyses using an age cut-off of 70+, as well
as in the post-hoc cross-sectional analysis evaluating
only those participants 80 + .
While our sample sizes were generally larger
than in most previous SCP studies, our statistical
power to detect small effect sizes was still rela-
tively limited. Therefore, we have also presented
initial results unadjusted for multiple comparisons.
While these exploratory observations must be inter-
preted with caution, they may be helpful in guiding
and/or interpreting future studies of super-aging with
larger sample sizes. Specifically, results prior to FDR
adjustment suggested that SCPs had decreased cere-
bral volume atrophy in the right banks of the superior
temporal sulcus (STS) and left lateral orbitofrontal
cortex. Of note, these associations were observed
in the discovery phase and these findings have
not been observed in previous published research.
Implications of these observations will be described
below.
Previous studies of SCP have been limited by the
lack of inclusion of amyloid imaging to allow for
exclusion of individuals in both the SCP and TOA
groups with potential preclinical AD. A novel con-
tribution of the present study was the longitudinal
sub-analyses with only cerebral A- participants,
thereby removing those individuals with increased
risk of developing AD. In the ROI phase of the
analyses and preceding FDR adjustment, attenuated
cortical thinning was observed in the right hemi-
sphere medial orbitofrontal region in the SCPs. In
addition, in the discovery phase analyses in SCPs,
cerebral volume preservation was seen in the right
hemisphere medial orbitofrontal region for A- par-
ticipants. Although not statistically significant, these
finding are similar to those reported by Sun et al.
[3] and Harrison et al. [6], who found significantly
decreased cortical thickness in TOAs compared to
SAs/successful agers in the medial prefrontal cor-
tex more broadly. Finally, our exploratory analyses
revealed cerebral volume preservation in the right
banks of the STS, which had not been observed in pre-
vious studies of super-aging. Of note, however, while
the evaluation of an entirely amyloid negative group
of SCPs was a strength, the sample size of this dis-
tinct group remained quite limited and the potential
role of amyloid status in this construct needs further
investigation.
The regions identified in the current study as possi-
ble regions of interest (the orbitofrontal cortices and
right STS) are notable for mediating neural processes
that may be relevant for super-aging, including supe-
rior memory and executive functions. For example,
Wilson and colleagues state that the anterior dorsal
bank of the STS contains representations reflect-
ing patterns of activity that “encode abstract lexical
entries, but do not contain phonological, ortho-
graphic, semantic or syntactic information. Rather,
these lexical nodes serve as hubs that bind together
these different types of information” [27]. Insights
into the importance of these areas to the maintenance
of superior memory can be inferred from studies
which show damage to this region interferes with
the links between meanings and word forms, but
not with the meanings and word forms themselves
[28]. Therefore, this region appears to contribute
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vital neural connections between words and their
conceptual underpinnings, and volume loss may be
associated with difficulty in retrieval or recognition
of verbal information due to the interruption of these
linkages.
Bilateral medial and lateral orbitofrontal cor-
tex thickness and volume were also identified as
potentially associated with superior cognitive per-
formance status in the present study. These regions
are involved in adaptive and goal-directed behav-
ior, including decision-making [29]. In particular, the
medial orbitofrontal cortex is thought to be impor-
tant in regulating goal-directed response selection,
which involves predicting the consequences of one’s
actions and the value of potential payoffs [30]. The
medial prefrontal region, of which the orbitofrontal
cortex lies within, is part of the default mode circuitry,
a major intrinsic brain network. The default mode
network is implicated in episodic memory processes
including encoding, storage, and retrieval [3].
Age-related atrophy is particularly prominent in a
number of regions including the prefrontal cortex [31,
32], and it is conceivable that loss of volume and/or
cortical thickness in this region would result in a
decline in episodic memory due to the integrity of the
default mode network being compromised. Of note,
however, these conclusions must be interpreted with
caution due to the lack of significant findings post
FDR adjustment, perhaps due to our limited sample
size.
Another novel contribution of the present study
is the methodological rigor used for group classifi-
cation. This is the first study that identified SCPs
and TOAs based on comprehensive and longitudi-
nal stability of cognitive performance and functional
ability. This likely increased the reliability of the SCP
classification and removed individuals from the TOA
group with preclinical dementia status. We believe
that this is an important step forward in the study of
the SCP construct, which increases the confidence in
our current pattern of results. Previous cross-sectional
studies have not been able to confidently exclude
“at risk” individuals from their TOA group, and it is
quite likely that without amyloid imaging or longitu-
dinal data a subset of their TOA group would include
such individuals. Further our post-hoc cross-sectional
analysis of participants 80+, produced similar results
to the primary analysis. The finding that 40% of the
aged 80 + SCP group are A+ is of interest, as these
participants have amyloid pathology; however, still
perform exceptionally well at multiple timepoints.
Such a cohort will be worth following to define
predictors of resilience to amyloid pathology in a
larger sample size.
Our findings suggest that even older adults (aged
70+) who maintain a high level of memory func-
tion and perform at a level 25 or more years younger
than their peer group, still show age-related changes
in brain morphology similar to peers with age-
consistent memory functions. Therefore, the question
remains as to how these individuals maintain this
level of cognitive function whilst brain changes are
progressing at a normal rate. Cognitive reserve (CR)
is a likely factor in accounting for the findings in the
extant SCP literature.
Cognitive reserve is developed by a lifetime of edu-
cation and cognitively enriching experiences to help
the brain better cope with any failures or declines
it faces. Cognitive reserve provides resilience to
acquired neuropathology, and therefore cognitive and
functional changes develop at a later stage for indi-
viduals with high CR compared to individuals with
low CR despite similar levels of neuropathology [33].
This is to be contrasted with one view of the super-
aging construct, in which SAs are thought to be
resilient to the development of neuropathology itself
well into advanced age. For example, an autopsy
study of SAs showed decreased AD pathological
changes compared to TOAs, and the authors con-
cluded that a decrease in AD pathology may underlie
SAs resistance to changes in memory performance
[34]. However, Harrison et al. [6] acknowledge that
it remains unclear whether successful agers avoid
neuropathology or are simply resilient to the effects
of such pathologies for an undetermined length of
time, and that this remains an under-explored area of
research. It could be argued that the findings of the
present study support the latter explanation—that is,
that successful agers remain resilient to the cognitive
and behavioral consequences of neuropathology for
an extended period of time. That is, they display high
CR. Of note, the SCPs and TOAs in the current study
did not differ in level of education (percentage of
those with less than or equal to 12 years of education,
and percentage with greater than 12 years of educa-
tion), and education level is often used as a proxy
for cognitive reserve. However, education is gener-
ally considered a crude and imperfect indicator of
CR, and some have argued for alternative indicators
(e.g., [35]). It will be important for future research to
more comprehensively assess potential differences in
cognitive reserve between those with SCP and TOAs.
Of note, however, given that the present results
from LMMs defined the rate of atrophy for both
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TOA and SCP participants to be very similar, post-
hoc sample size calculations revealed that to find a
clinically meaningful difference, studies would need
an unrealistic number of participants to be followed
up over a similar time period. In summary, despite
the lack of statistically significant brain morpholog-
ical differences between SCPs and TOAs reported
in the present study, our findings do not preclude
the possibility of super-agers, as contrasted from a
group of individuals with high brain or cognitive
reserve.
The present study also expanded on our under-
standing of the way amyloid load fits into the SCP
construct initiated in Dang et al. [8]. We observed
the SCPs and TOAs did not significantly differ on
percentage of those classed as A+, and the results
did not differ when the A- sub sample was analyzed
independently.
There are limitations to our findings; specifically,
a relatively small sample size of 76 SCPs and 100
TOAs were studied, with a maximum of 41 and 43
participants in each group with MRI data at any one
time point, reducing further when 3 or more MRI
scan were included. However, post-hoc sample size
calculations indicate that very large samples would
be needed to be able to detect a clinically meaning-
ful and significant difference in the atrophy slopes
between these two groups. This sample size prob-
lem remains a challenge in any study of super-aging,
which is thought to be relatively rare, even in large
cohort studies such as AIBL. When individuals that
are A+ are excluded, the numbers decrease even fur-
ther. Very large cohort studies will be required to more
thoroughly evaluate the validity of the super-aging
construct.
In summary, we here reported that SCPs and
TOAs in our cohort did not display differing tra-
jectories of cortical thinning and volume atrophy
over six years, even when only A- participants
were analyzed. The findings from this cohort pro-
vide preliminary evidence that whilst maintenance
of superior memory may be a biological possibility,
it may not coincide with decreased cerebral changes
associated with aging, including cortical thinning and
volume atrophy. Further longitudinal studies with
amyloid negative participants are required to replicate
our findings. Future research will additionally eluci-
date potential pathways for the resistance of SCPs
to age-related cognitive, identify factors that pro-
mote successful aging, and evaluate whether these
relationships are consistent across racial, ethnic, and
socioeconomic groups.
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